Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Studied population Approximately 200 patients will be enrolled with inconclusive or equivocal findings after the standard clinical/diagnostic flow chart: \[18F\]F-FDG PET/CT imaging not able to solve the clinical doubt or equivocal/inconclusive for the evaluation of oncological disease. Patients enrolled must satisfy all the inclusion criteria and must sign an informed consent. The informed consent will be signed by the patient in the nuclear medicine department before the performance of any experimental procedure. Primary aim Secondary aim To evaluate the accuracy of \[68Ga\]Ga-FAPI PET/CT in detecting the presence of oncological disease in patients with inconclusive or equivocal findings after the standard clinical/diagnostic flow chart: \[18F\]F-FDG PET/CT imaging not able to solve the clinical doubt or equivocal/inconclusive for the evaluation of oncological disease. To evaluate accuracy, sensitivity and specificity of \[68Ga\]Ga-FAPI PET/CT and \[18F\]F-FDG PET/CT (standard examination currently performed in several oncological settings) in detecting the presence of oncological disease in patients with inconclusive or equivocal findings after the standard clinical/diagnostic flow chart: \[18F\]F-FDG PET/CT imaging not able to solve the clinical doubt or equivocal/inconclusive for the evaluation of oncological disease. Primary endpoint accuracy of \[68Ga\]Ga-FAPI PET/CT in detecting the presence of oncological disease in patients with inconclusive or equivocal findings after the standard clinical/diagnostic flow chart: \[18F\]F-FDG PET/CT imaging not able to solve the clinical doubt or equivocal/inconclusive for the evaluation of oncological disease. Secondary enpoint accuracy, sensitivity and specificity of \[68Ga\]Ga-FAPI PET/CT and \[18F\]F-FDG PET/CT (standard examination currently performed in several oncological settings) in detecting the presence of oncological disease in patients with inconclusive or equivocal findings after the standard clinical/diagnostic flow chart: \[18F\]F-FDG PET/CT imaging not able to solve the clinical doubt or equivocal/inconclusive for the evaluation of oncological disease.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
